Immunoassay vs LC-MS/MS for Total T
Why Cheap Testosterone Panels Are Unreliable at Low Ranges
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Assays run in CLIA labs; LC-MS/MS is the reference-method standard, not an FDA drug
Reference only. Not medical advice.
What can go wrong
Relying on a non-standardized immunoassay near the diagnostic threshold can both miss true hypogonadism and manufacture false low results that lead to unnecessary TRT. Method differences also corrupt comparisons across panels and over time if a man switches labs.
This is something to take to a clinician. The Atlas can tell you what is known about immunoassay vs lc-ms/ms for total t in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Total testosterone is measured two main ways: automated immunoassay (fast, cheap, used on high-throughput analyzers) and liquid chromatography-tandem mass spectrometry (LC-MS/MS, the reference method). The Endocrine Society and the CDC's Hormone Standardization (HoSt) program endorse LC-MS/MS or otherwise CDC-certified assays for accuracy. Immunoassays are known to be least reliable precisely at the low concentrations that matter for diagnosing hypogonadism - and at the very low ranges found in women and children. A bargain panel that runs immunoassay can mislabel a man as low or normal at the decision threshold.
The same blood, two methods, two different 'verdicts' on your testosterone.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Immunoassays use antibodies to bind testosterone; cross-reactivity with structurally similar steroids and matrix effects degrade specificity, worst at low concentrations. LC-MS/MS physically separates testosterone by chromatography and identifies it by mass-to-charge ratio against an isotope-labeled internal standard, giving high specificity and accuracy across the range. CDC HoSt certifies assays that agree with the reference method within defined limits.
The marketing skips the method line
Consumer panels rarely advertise which method they run. A man comparing a $40 panel to a clinic's quote is usually comparing an immunoassay to nothing he can see. Near the ~264-300 ng/dL decision zone, immunoassay imprecision and bias can move a result across the line, which is exactly where a borderline call triggers therapy. Asking 'is this LC-MS/MS or CDC-certified?' is the single most useful consumer question and is almost never surfaced in the funnel.
What people get wrong
Often saidA testosterone number is a testosterone number
ActuallyThe same sample can yield materially different values by method. Without knowing the assay, a single figure is not comparable to published reference ranges or to a prior result from another lab.
Often saidMass spec is just a fancier, costlier version of the same answer
ActuallyAt low ranges it is not cosmetic - immunoassays are specifically least trustworthy where the diagnostic decision is made.
Who profits, and who pushes back
William Rosner, MD
Direct immunoassays for testosterone are inaccurate, especially at the low end, and should not be used where precision matters.
Hubert Vesper, PhD
Standardization to a reference method is what lets a testosterone result mean the same thing across labs.
What we do not know
- What fraction of DTC men's-health panels disclose their testosterone assay method?
- How many borderline 'low T' diagnoses would reclassify if confirmed by LC-MS/MS?
At a glance
- Reference method
- Isotope-dilution LC-MS/MS
- Standardization program
- CDC HoSt (Hormone Standardization)
- Weakest immunoassay zone
- Low T concentrations (and women/children ranges)
- Why it matters
- Diagnosis hinges on values near the lower threshold
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Immunoassay vs LC-MS/MS for Total T. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
CDC Hormone Standardization (HoSt) Programongoing since ~2010
Established reference measurement and certification so testosterone assays agree with isotope-dilution LC-MS/MS
Rosner et al., position statement on testosterone assays2007
Documented poor accuracy of direct immunoassays at low concentrations and called for mass-spectrometry-based or otherwise validated methods
Endocrine Society guideline measurement recommendation2018
Recommends measuring testosterone with an accurate, reliable, ideally CDC-certified assay